Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LENZ Therapeutics Inc
LENZ | US
9.38
USD0.23
2.51%
LENZ | US
Loading StockChartView...
About LENZ Therapeutics Inc
Sector
6/25/2021
Industry
6/25/2021
Earnings date
30/06/2024
As of date
24/04/2026
Close
9.38
Open
9.31
High
9.48
Low
8.95
View Less
LENZ | US
Risk
65.2
Sharpe
-0.89
Luna's Score
45/100
Recommendation
Sell
Luna says (LENZ | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
67.1%1 month
65.2%3 months
73.4%6 months
88.3%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.11
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-7.99
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-75.26M
MarketCap
201.23M
MarketCap(USD)
201.23M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-157.61
Short ratio
17.72
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.44
Range1M
2.14
Range3M
13.43
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.71
Price X volume
6.15M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.99 | - | - |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | - | - |
| Price to Book | 3.11 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 73.36 | - | - |
| Debt to Equity | 0.01 | - | - |
| Debt to Assets | 0.01 | - | - |
| Market Cap | 201.23M | - | - |
